KIR <sup>+</sup> CD8 <sup>+</sup> T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19Jing Li, Mark M. Davis, Maxim Zaslavsky et al.|Science|2022Cited by 244
Targeted Nanocarriers Co-Opting Pulmonary Intravascular Leukocytes for Drug Delivery to the Injured BrainJia Nong, Oscar A. Marcos‐Contreras, Zhicheng Wang et al.|ACS Nano|2023Cited by 28
Marginated Neutrophils in the Lungs Effectively Compete for Nanoparticles Targeted to the Endothelium, Serving as a Part of the Reticuloendothelial SystemMarco E. Zamora, Eno‐Obong Essien, Kartik Bhamidipati et al.|ACS Nano|2024Cited by 25
Human KIR+ CD8+ T cells target pathogenic T cells in Celiac disease and are active in autoimmune diseases and COVID-19Jing Li, Mark M. Davis, Maxim Zaslavsky et al.|The Journal of Immunology|2022Cited by 11
Human KIR <sup>+</sup> CD8 <sup>+</sup> T cells target pathogenic T cells in Celiac disease and are active in autoimmune diseases and COVID-19Jing Li, Mark M. Davis, Maxim Zaslavsky et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 2